`

IRLAB Therapeutics AB

Biotechnology Research

Sign Up to View More
revenue-icon Revenue
101M - 500M
funding-icon Total Funding
$1.98M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About IRLAB Therapeutics AB

What does Irlab therapeutics ab do?+

IRLAB discovers and develops novel treatments of Parkinsons disease and other CNS disorders. The companys most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinsons . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam. IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its proprietary systems biology-based Integrative Screening Process (ISP) research platform. In addition to IRLABs strong clinical...

What is Irlab therapeutics ab's industry? +

Irlab therapeutics ab operates in the Biotechnology research industry.

What is Irlab therapeutics ab's revenue? +

Irlab therapeutics ab's revenue is 101m - 500m

What is Irlab therapeutics ab's company size? +

Irlab therapeutics ab has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free